Delivery Order SPE2DB24D2101-SPE2DB25FKPQB
- Not listed
- The Defense Logistics Agency awarded a $16,250.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringe format on September 11, 2025, with completion targeted for September 12, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $17,790.58 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes on August 15, 2025, with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's Conshohocken, Pennsylvania location. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $3,267.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringe configuration, with an ultimate completion date of July 18, 2025. This non-set-aside contract was competitively awarded on July 17, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under...
- The Defense Logistics Agency awarded a delivery order valued at $12,901.75 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine syringes (0.5 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $38,736.16 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of August 27, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $16,393.87 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringe format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 10, 2025. The award was issued on September 9, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $35,994.63 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 vaccines in 0.5ML syringes, with an ultimate completion date of September 8, 2025. This competitively awarded, non-set-aside contract was issued on September 5, 2025, with firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,997.09 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes under a firm fixed-price contract type. This non-set-aside award was issued on May 2, 2025, with an ultimate completion date of May 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5 milliliter syringes. The contract, executed on May 27, 2025, with a completion date of May 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location and serves as the prime contractor. This award is issued...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPQBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringes. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive, non-set-aside award to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive contract portfolio with the DLA and Defense Health Agency. The company's demonstrated capability to fulfill federal medical supply requirements across diverse therapeutic domains—including vaccines, specialty medications, and medical devices—positions it as a primary supplier for military and veteran healthcare systems. PREVNAR 20 is a pneumococcal vaccine commonly administered to military personnel and beneficiaries as part of preventive health programs, making this supply requirement consistent with the company's role in supporting the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/16/25 |